Does BIBW 2992 Cause Malignant neoplasm progression? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Malignant neoplasm progression have been filed in association with BIBW 2992. This represents 12.0% of all adverse event reports for BIBW 2992.
6
Reports of Malignant neoplasm progression with BIBW 2992
12.0%
of all BIBW 2992 reports
6
Deaths
4
Hospitalizations
How Dangerous Is Malignant neoplasm progression From BIBW 2992?
Of the 6 reports, 6 (100.0%) resulted in death, 4 (66.7%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BIBW 2992. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does BIBW 2992 Cause?
Diarrhoea (16)
Nausea (8)
Vomiting (8)
Renal failure acute (7)
Asthenia (5)
Decreased appetite (5)
Rash (5)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)